Evidence map›Paper›PMID 37763123›Full record

ArticleJournal of personalized medicine2023

The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy-A Multicentre Retrospective Cohort Study.

Emma Schulz Hägersten, Kristoffer Ottosson, Sofia Pelander, Markus Johansson, Ylva Huge, Firas Aljabery, Farhood Alamdari, Johan Svensson, Johan Styrke, Amir Sherif

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Emma Schulz HägerstenDepartment of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 907 36 Umea, Sweden.
Kristoffer OttossonDepartment of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 907 36 Umea, Sweden.
Sofia PelanderDepartment of Clinical and Experimental Medicine, Division of Urology, Linkoping University, 581 83 Linkoping, Sweden.
Markus JohanssonDepartment of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 907 36 Umea, Sweden.
Ylva HugeDepartment of Clinical and Experimental Medicine, Division of Urology, Linkoping University, 581 83 Linkoping, Sweden.ORCID 0009-0004-2332-0653
Firas AljaberyDepartment of Clinical and Experimental Medicine, Division of Urology, Linkoping University, 581 83 Linkoping, Sweden.
Farhood AlamdariDepartment of Urology, Vastmanland Hospital, 721 89 Vasteras, Sweden.
Johan SvenssonDepartment of Statistics, Umea School of Business, Economics and Statistics, Umea University, 907 36 Umea, Sweden.ORCID 0000-0002-8601-0159
Johan StyrkeDepartment of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 907 36 Umea, Sweden.
Amir SherifDepartment of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, 907 36 Umea, Sweden.ORCID 0000-0002-3675-3050
Umeå University · SELinköping University · SELänssjukhuset Sundsvall-Härnösand · SEVästmanlands sjukhus Västerås · SE

Funding

The Swedish Research Council funding for clinical research in medicine (ALF) in Västerbotten, VLL, Umeå, Sweden Bas-ALF/VLL RV-848051
6 · The paper itself

Abstract

purposePrevious studies have indicated that patients with muscle-invasive bladder cancer with non-O blood types have an increased risk of experiencing thromboembolic events (TEEs). This is finding is in relation to neoadjuvant-chemotherapy (NAC)-naïve patients.

aimto establish the risk of TEEs and any association with blood types among NAC patients as well as NAC-naïve patients.

methodsCystectomized patients at four centres treated from 2009 to 2018 (

resultsSixty-six TEEs were detected in 21% of the patients (

conclusionsNo significant associations were found between blood types and TEE occurrences in this cohort including both NAC and NAC-naïve NAC-eligible patients.

Indexed as

ABO blood group systemcomplicationscystectomyneoadjuvant therapythromboembolismurinary bladder neoplasms

Identifiers

PMID37763123
PMCPMC10533159
OpenAlexW4386423235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.